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The effect of the 7 different molecular forms of human pituitary lutropin (LH) on mouse Leydig cells as 
a model of a target organ were studied. The hormone functions have been characterized by receptor 
binding, CAMP accumulation and testosterone production. One important finding was the similar intrinsic 
in vitro biological activity for all isohormones. Quantitatively, however, the potencies of the 7 hormone 
forms did not correlate with the activities obtained by radioimmunoassay: there was a dramatic decrease 
of receptor binding activity and biological activity compared to immunoactivity from the more alkaline 
to the more acidic LH isohormones. 
Human lutropin Isohormone Leydig cell Receptor binding CAMP production 
Testosterone production 
1. INTRODUCTION 
Several studies have indicated that pituitary 
lutropin (LH) from human and other species exists 
as a number of differently charged molecular 
forms in unprocessed aqueous pituitary extracts 
[1,2]. Recently, we were able to demonstrate the 
complete microheterogeneous ystem of human 
pituitary LH by gel isoelectric focusing. Further- 
more, the 7 LH forms could be isolated by 
preparative column focusing and partially 
characterized [3]. However, it is not known 
whether the various isohormones play different 
roles in the regulation of target organ function. To 
answer this question we have studied the effect of 
the 7 molecular forms of human LH on receptor 
binding, CAMP accumulation and testosterone 
production in mouse Leydig cells. Mouse Leydig 
cells were chosen as a target organ model for the 
different LH forms because this in vitro system is 
well defined with respect to responsiveness to the 
multi-component system of human chorionic 
gonadotropin and lutropin [4]. 
2. MATERIALS AND METHODS 
2.1. Preparation of hLH isohormones 
LH isohormones were prepared from frozen 
human pituitaries by extraction, gel filtration and 
preparative column isoelectric focusing as in [3]. 
2.2. Immunological characterization of the 
hLH forms 
Abbreviations: CAMP, adenosine 3 ’ ,5 ‘-cyclic phos- 
phoric acid; hCG, human chorionic gonadotropin; hLH, 
human luteinizing hormone; MIX, I-methyl-3-isobutyl- 
xanthine; MEM, Eagle’s minimum essential medium; 
RRA, radioreceptor assay 
Radioimmunological hLH concentration was 
measured using the NIAMDD-hLH kit. The LH 
preparations I-l and MRC 68/40 were used for 
iodination and as a standard, respectively. All 
assays were performed with antiserum to hLH, 
batch no.2. Complete dose-response curves for all 
7 isohormones were constructed by serial dilutions. 
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Parallelism between the different LH isohormones 
was tested by analysis of variance comparing the 
slopes of the logit-log regression lines. 
2.3. Preparation of Leydig cells 
A crude mouse Leydig cell suspension was 
prepared by a non-enzymatic procedure as in [4] 
and purified (90-95% Leydig cells) by Percoll@ 
density gradient centrifugation according to [5]. 
2.4. Receptor-binding experiments 
Highly purified hLH (I-l, NIAMDD) was 
radioiodinated with “‘1 by the lactoperoxidase 
method. The specific activity was 40-60 mCi/mg 
and the maximal binding activity of the labeled 
hormone with an excess of receptor sites was about 
40%. The initial ratio of bound to total counts was 
15-20% and the nonspecific binding l-2%. Ap- 
prox. lo5 Leydig cells in 500~1 MEM were in- 
cubated with serial dilutions of identical radioim- 
munological concentrations of the 7 LH isohor- 
mones in the presence of 20000 cpm 1251-hLH for 
2 h at 37°C. The incubation was terminated by 
dilution and centrifugation, and the radioactivity 
bound to the cell pellet was measured in a gamma- 
counter. Parallelism of the dose-response curves 
was tested as described in section 2.2. 
2.5. CAMP accumulation 
Approx. lo4 Leydig cells in 300 ~1 MEM were in- 
cubated for 3 h at 37°C with the 7 LH isohor- 
mones in the presence of 0.5 mM MIX. Incuba- 
tions were stopped by addition of ethanol (80% 
Table 1 
Isoelectric points (pl) and slopes of radioimmunoassay 
(RIA) and radioreceptor assay (RRA) dose-response 
curves for the 7 LH isohormones 
LH component pZ RIA RRA 
no. slope slope 
1 8.8 0.91 f 0.05 1.36 f 0.12 
2 8.4 0.87 f 0.06 1.35 + 0.09 
3 7.8 0.91 +- 0.06 1.26 f 0.05 
4 7.4 0.90 + 0.03 1.16 + 0.02 
5 6.9 0.92 f 0.05 1.13 f 0.06 
6 6.5 0.92 f 0.03 1.07 k 0.07 
7 5.9 0.90 + 0.07 1.04 * 0.03 
Values are the means -+ SD of 4 assays 
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final concentration). After centrifugation the 
supernatant was evaporated and the CAMP 
redissolved in water. Total CAMP (intra- and ex- 
tracellular) was measured by specific RIA. Com- 
plete dose-response curves were constructed using 
multiple doses of the LH isohormones. 
2.6. Testosterone production 
The incubation conditions were the same as 
described in section 2.5 but without addition of 
MIX. Incubations were stopped by dilution with 
10 vols cold MEM. Testosterone production was 
measured by RIA of unextracted cell medium as in 
[6]. A parallel line bioassay design was employed 
to test parallelism and potencies for the CAMP and 
testosterone production assay. 
3. RESULTS 
When serial dilutions of the 7 isohormones 
separated by column isoelectric focusing of a 
purified LH preparation were tested in the hLH- 
RIA, all dose-response curves were parallel to each 
other and to the MRC 68/40 LH standard as 
shown in table 1. These results indicate that the im- 
munochemical nature of the different hLH com- 
ponents is identical at least for the anti-hLH serum 
used here. 
On the basis of identical immunological hor- 
mone concentrations, inhibition curves of the 7 
isohormones were constructed in a radioreceptor 
assay system using isolated intact Leydig cells as 
the receptor source. As shown in fig.lA all LH 
species were able to compete with the radiolabeled 
LH on the receptor sites. However, there was a 
stepwise decrease of the slopes of the dose- 
response curves from 1.36 to 1.04 with decreasing 
pZ values of the isohormones (table 1). Thus, a 
higher relative affinity to the receptor of the more 
alkaline hormone forms is indicated. This correla- 
tion was also revealed by a stronger receptor- 
binding activity for the more alkaline LH forms as 
calculated from the 50% intercept (EDSO = 
100 mIU/ml for the 68/40 standard) of the various 
dose-response curves. The ratios of receptor- 
binding activity to radioimmunoactivity ranged 
from 2.34 to 0.23 (fig.2). 
Stimulation of purified Leydig cells with the dif- 
ferent isohormones in the presence of the 
phosphodiesterase inhibitor MIX resulted in iden- 
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Fig.1. Effect of increasing immunoreactive concentra- 
tions of the 7 LH forms (l-7) on “‘1-hLH binding to 
mouse Leydig cells (A), CAMP accumulation (B) and 
testosterone production (C) by mouse Leydig cells. 
Dose-response curves were constructed from the mean 
values of 4 doses for each LH form in 4 different assays. 
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Fig.2. Relationship between biological activities 
(receptor-binding activity, CAMP and testosterone 
production activity) and radioimmunoactivity (RIA) of 
the 7 LH isohormones (l-7). Results are means + SD of 
4 assays. 
tical m~imum CAMP accumulation (20 pmoll 
tube) after 3 h incubation. Furthermore, all dose- 
response curves were parallel to each other and to 
the 68/40 standard preparation (ED50 = 4 mIU/ 
ml). However, a discrepancy between bioactivity 
(B) with respect to CAMP accumulation and im- 
munoreactivity (I) could be observed. The B:f 
ratios for hLH components l-7 ranged between 
1.44 and 0.33. 
Finally, determination of the androgen- 
producing activity of the LH isohormones showed 
that Leydig cells were stimulated maximally by the 
different LH forms. This was expressed in iden- 
tical maximal testosterone production rates, as 
shown in fig.lC. All dose-response curves were 
parallel, the EDSO being 0.5 mIU/ml (68/40) and 
maximal testosterone production 20 ng/tube. The 
B:f ratios for the isohormones were in the same 
range (1.47-0.38) as for cAMP accumulation 
(fig.2). 
4. DISCUSSION 
The responses of rat and mouse Leydig cells to 
gonadotropic hormones in vitro have been exten- 
sively evaluated (review 171). The stimulating hor- 
mones used in these studies were hCG or LH. 
However, it must be borne in mind that these hor- 
mones, even in their highly purified form, consist 
of 6 (hCG) and 7 (LH) differently charged forms, 
23 
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We have here demonstrated that all 7 immunoreac- 
tive human LH isohormones appear to have 
similar intrinsic biological potencies at least with 
respect to maximal CAMP accumulation and 
testosterone production of isolated mouse Leydig 
cells. However, all LH components showed small 
but significantly different relative affinities to the 
receptors of intact Leydig cells. These minor dif- 
ferences have no influence on the m~imum 
amount of testosterone secreted by the Leydig 
cells, as it is well known that only 1% of all recep- 
tor sites need to be occupied to elicit the 
steroidogenic maximum [7]. 
Besides maximal response a further component 
of responsiveness i the sensitivity of the response 
(E&O) [S]. The absolute .,!X& values for hormone 
competition, CAMP accumulation, as well as 
testosterone production are not deducible from the 
present data because potency comparison between 
the isohormones was made on the basis of identical 
immunoreactive concentrations rather than on a 
mass basis. Thus, the relative biological potencies 
were expressed as B:I ratios. As shown in fig.2 
there was a dramatic decrease in the ratio between 
receptor-binding activity and immunoreactivity 
from the most alkaline (component 1) to the more 
acidic (component 7) hLH isohormone, These 
results largely agree with those reported for rat LH 
isohormones [2], The high receptor-binding activi- 
ty of hLH 1 and hLH 2 did not correlate with the 
CAMP accumulation and testosterone production 
assay. Nevertheless, a significant decrease in the 
B:f ratios was found for LH components 5-7. 
This is in accordance with [i] in which lower B:I 
ratios were also reported for the more acidic LH 
forms of crude pituitary extracts. The low B:I 
ratios of the more acidic LH forms indicate that 
the physico-chemical properties of these forms 
may differ in such a way that they may have an ef- 
feet on the stimulation of the cell rather than on 
the affinity to the antibody. From our data we con- 
clude that the immunological nature of the isohor- 
mones is identical. In this context it would be of in- 
terest to determine whether monoclonal antibodies 
are able to differentiate between isohormones. 
The results discussed here deal only with in vitro 
effects of the different hLH forms on the target 
cells and not with the survival of the components 
in the circulation. Such studies in progress. 
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